James Brush - 30 Jan 2025 Form 3 Insider Report for Maze Therapeutics, Inc. (MAZE)

Role: Director
Signature: /s/ Courtney Phillips, as attorney-in-fact
Issuer symbol: MAZE
Transactions as of: 30 Jan 2025
Net transactions value: $0
Form type: 3
Filing time: 30 Jan 2025, 16:27:19 UTC
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MAZE	Series D Preferred Stock							30 Jan 2025	Common Stock	12,148,191		Frazier Life Sciences Public Fund, L.P.	F1, F2
holding	MAZE	Series D Preferred Stock							30 Jan 2025	Common Stock	3,583,732		Frazier Life Sciences Public Overage Fund, L.P.	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the Issuer's Restated Certificate of Incorporation, each share of Series D Convertible Preferred Stock may be converted, at the option of the holder, at any time. In connection with the completion of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock shall automatically convert into shares of Common Stock at a ratio of 1-for-0.1037236801. The securities have no expiration date.
F2	These shares are held directly by Frazier Life Sciences Public Fund L.P. The general partner of Frazier Life Sciences Public Fund L.P. is FHMLSP, L.P. and the general partner of FHMLSP, L.P. is FHMLSP, L.L.C. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P., FHMLSP, L.L.C. and the reporting person each disclaim beneficial ownership of the shares held by Frazier Life Sciences Public Fund L.P., except to the extent of their respective pecuniary interests therein, if any.
F3	These shares are held directly by Frazier Life Sciences Public Overage Fund L.P. The general partner of Frazier Life Sciences Public Overage Fund L.P. is FHMLSP Overage, L.P. and the general partner of FHMLSP Overage, L.P. is FHMLSP Overage, L.L.C. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., and the reporting person each disclaim beneficial ownership of the shares held by Frazier Life Sciences Public Overage Fund L.P., except to the extent of their respective pecuniary interests therein, if any.